These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 26238078

  • 1. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K, Sano K, Makino A, Shimizu Y, Yamauchi F, Ogawa S, Ding N, Yano T, Temma T, Ono M, Saji H.
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [Abstract] [Full Text] [Related]

  • 2. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
    Sano K.
    Yakugaku Zasshi; 2017 Nov; 137(1):55-60. PubMed ID: 28049896
    [Abstract] [Full Text] [Related]

  • 3. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N, Sano K, Kanazaki K, Ohashi M, Deguchi J, Kanada Y, Ono M, Saji H.
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.
    Xi L, Grobmyer SR, Zhou G, Qian W, Yang L, Jiang H.
    J Biophotonics; 2014 Jun; 7(6):401-9. PubMed ID: 23125139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging.
    Bogdanov AA, Dixon AJ, Gupta S, Zhang L, Zheng S, Shazeeb MS, Zhang S, Klibanov AL.
    Bioconjug Chem; 2016 Feb 17; 27(2):383-90. PubMed ID: 26603129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
    Li X, Xia S, Zhou W, Ji R, Zhan W.
    Int J Nanomedicine; 2019 Feb 17; 14():2397-2413. PubMed ID: 31040664
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sensitive Photoacoustic/Magnetic Resonance Dual Imaging Probe for Detection of Malignant Tumors.
    Ding N, Sano K, Kanazaki K, Shimizu Y, Watanabe H, Namita T, Shiina T, Ono M, Saji H.
    J Pharm Sci; 2020 Oct 17; 109(10):3153-3159. PubMed ID: 32679213
    [Abstract] [Full Text] [Related]

  • 16. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
    Satpathy M, Wang L, Zielinski RJ, Qian W, Wang YA, Mohs AM, Kairdolf BA, Ji X, Capala J, Lipowska M, Nie S, Mao H, Yang L.
    Theranostics; 2019 Oct 17; 9(3):778-795. PubMed ID: 30809308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.